| There are just a few treatment options available | | | | been shown to slow down or improve this retinal |
| for macular degeneration. More specifically, there | | | | disease. |
| are only treatments available for the wet form. | | | | A second study, AREDS 2, is underway. AREDS 2 |
| There are none for dry macular degeneration. | | | | will directly study the value of macular |
| Vitamins for the Eyes - Despite what you may | | | | xanthophylls (lutein and zeaxanthin) in our diet, the |
| read on the Internet or hear on the radio, | | | | value of omega 3 fatty acids and their role in |
| vitamins are not helpful for most patients with | | | | macular eye disease, cardiovascular disease and |
| macular degeneration. Only a small subset of | | | | dementia, and the role of beta-carotene. |
| "intermediate and high risk" patients with the wet | | | | AREDS 2 will be complete in about 5 years. |
| form can derive a benefit from supplements. | | | | To summarize, the AREDS 1 study was the only |
| The AREDS study (Age Related Eye Disease | | | | eye study that found evidence that nutritional |
| Study), an NIH funded study, found that patients | | | | supplements provides some value. The AREDS |
| with intermediate or high-risk characteristics, had a | | | | formulation is indicated only for patients with |
| decreased chance of severe vision loss if specific | | | | moderate/high risk characteristics of macular |
| supplements were taken. The study found that | | | | degeneration and reduces the chance of |
| the chance of severe vision loss decreased from | | | | developing severe vision loss. It is not a cure, but |
| 28% to 21%. That's all. This became known as | | | | a potential treatment. It is not indicated for |
| the AREDS formulation. | | | | everyone. |
| The AREDS formula contains vitamin C, vitamin E, | | | | There have not been any other formal studies |
| beta-carotene and zinc. Lutein and zeaxanthin | | | | indicating the value of any other supplements for |
| have never been directly studied and neither has | | | | the eyes. |